HDAC inhibitor Vorinostat and BET inhibitor Plx51107 epigenetic agents’ combined treatments exert a therapeutic approach upon acute myeloid leukemia cell model-Reference-Cited by-同舟云学术

HDAC inhibitor Vorinostat and BET inhibitor Plx51107 epigenetic agents’ combined treatments exert a therapeutic approach upon acute myeloid leukemia cell model

Published:2022-10-12 Issue:12 Volume:39 Page:
ISSN:1559-131X
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Alcitepe İlayda,Salcin Hilal,Karatekin İlknur,Kaymaz Burcin Tezcanli^ORCID

Funder

Ege University Research Foundation

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12032-022-01858-x.pdf

Reference43 articles.

1. Abedin SM, Boddy CS, Munshi HG. BET inhibitors in the treatment of hematologic malignancies: current insights and prospects. OncoTargets Ther. 2016. https://doi.org/10.2147/OTT.S100515.

2. Attia SM, Al-Khalifa MK, Al-Hamamah MA, Alotaibi MR, Attia MSM, Ahmad SF, et al. Vorinostat is genotoxic and epigenotoxic in the mouse bone marrow cells at the human equivalent doses. Toxicology. 2020. https://doi.org/10.1016/j.tox.2020.152507.

3. Boi M, Gaudio E, Bonetti P, Kwee I, Bernasconi E, Tarantelli C, et al. The BET bromodomain inhibitor OTX015 affects pathogenetic pathways in preclinical B-cell tumor models and synergizes with targeted drugs. Clin Cancer Res. 2015;21(7):1628–38.

4. Cengiz Seval G, Beksac M. A comparative safety review of histone deacetylase inhibitors for the treatment of myeloma. Expert Opin Drug Saf. 2019. https://doi.org/10.1080/14740338.2019.1615051.

5. Chen X, Burkhardt DB, Hartman AA, Hu X, Eastman AE, Sun C, et al. MLL-AF9 initiates transformation from fast-proliferating myeloid progenitors. Nat Commun. 2019;10(1):1–15.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Histone Deacetylase Inhibitor in Acute Myeloid Leukemia;PROG BIOCHEM BIOPHYS;2024

2. Targeting BRD4: Potential therapeutic strategy for head and neck squamous cell carcinoma (Review);Oncology Reports;2024-04-12

3. Acetyl-CoA metabolism as a therapeutic target for cancer;Biomedicine & Pharmacotherapy;2023-12

4. Seaweed Extracts as a Promising Natural Source Exert a Therapeutic Approach via Inducing Cytotoxicity and Apoptosis in Chronic Myeloid Leukemia Cell Model;2023-08-09

5. Potent bromodomain and extraterminal domain inhibitor JAB-8263 suppresses MYC expression and exerts anti-tumor activity in colorectal cancer models;World Journal of Gastrointestinal Oncology;2023-02-15